Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

1
Weight Loss Market Analysis, Global API
Manufacturers and Phase III Pipeline Assessment,
2014
2
Summary
'Weight Loss- Market Analysis, Global API
Manufacturers and Phase III Pipeline Assessment,
2014', report provides comprehensive insights
about phase III pipeline drugs and marketed drugs
across the indication. A key objective of the
report is to establish the understanding for API
Manufacturers for marketed and Phase III pipeline
drugs across the different countries and regions.
While the leading brands, companies and chemicals
are considered thoroughly, the report also
provides details on the drug master filings
across the US, Europe and Asia specifically China
and India. The research, analysis also presents
the global sales forecasts data till 2015. The
report is also giving insight about the patent
and exclusivity details of all the drugs across
the indication. Secondary sources information and
data has been collected from various printable
and non-printable sources like search engines,
News websites, Government Websites, Trade
Journals, White papers, Magazines, Trade
associations, Books, Industry Portals, Industry
Associations and access to available databases.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
3
Scope A snapshot of the global Market
therapeutics scenario for Weight Loss. A review
of the marketed products under prescription for
Weight Loss, regulatory information and marketing
status. Coverage of global patent coverage and
detailed commentaries on the US patent
challenges. Graphical representation of
investigational products for patent expiry and
market exclusivities across the globe. Product
profiles for marketed products for Weight Loss
with complete description of mechanism of action,
therapeutic class, target, route(s) of
administration and chemical details. Coverage
of API Manufacturers for Weight Loss drugs in the
United States, Europe and Asian Regions with
location details.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
4
Coverage of Regulatory filings in the US,
Europe, and Asia specifically India and China for
Weight Loss drugs. Coverage of Route of
Synthesis of Active Pharmaceutical Ingredient
associated with Weight Loss drugs. Coverage of
Weight Loss Phase III pipeline products featuring
sections on product description, mechanism of
action, Chemical details and research
development progress. Coverage of the United
States Drug Master File (US DMF) available for
Phase III Pipeline Drugs. Key discontinued
Marketed products. Global Sales Figure from
2011-2015.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
5
Reasons to buy Evaluate the marketing status
and exclusivity details of Weight Loss key
products to exploit opportunities for generic
drug development opportunities. Identify and
understand important and diverse types of
therapeutics under Phase III development for
Weight Loss. Design effective
counter-strategies to gain competitive advantage
by identifying the key patent expiry details and
exclusivity with respect to Weight Loss. API
intelligence over marketed drugs for Weight Loss
and gaining primary intelligence over active
ingredients manufacturers across the globe.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
6
API intelligence over leading Phase III
pipeline drugs. Develop and designstrategies
by identifying the API manufacturers for Phase
III pipeline products to enhance and expand
business potential and scope. Understanding
the scope of the Phase III Drugs with nil
regulatory filings. Understanding the chemical
route of synthesis of approved drugs for Weight
Loss. Uncovering opportunities in the rapidly
growing the US markets.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
7
Table of Contents
Indication Overview Marketed Drugs
Assessment Marketed Details of Drugs by
Application Type Marketed Details of Drugs
(NDA) by Marketing Status Marketed Details of
Drugs by Patent Expiration Timeline The Active
Pharmaceutical Ingredient (API) Manufacturers
Assessment The API Manufacturers by the United
States Drug Master File (US DMF) Status The API
Manufacturers by the US DMF Status (Drug
Specific) The Active Pharmaceutical Ingredient
(API) Manufacturers Assessment for Phase III
Pipeline Drugs The API Manufacturers by the US
DMF Status (Drug Specific) Drugs Market Data
and Forecasted Sales Figures (2011-2015)
Marketed Drugs Information
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
8
To view the full Executive Summary and Table of
Contents, please visit Weight Loss Market
Analysis, Global API Manufacturers and Phase III
Pipeline Assessment, 2014 Contact UsBharat
Book BureauCall us 91-22-27810772 / 73Email
id info_at_bharatbook.com Blog
https//www.bharatbook.com/blog/
Follow Us On